United Kingdom-Cardiff: Clinical Trials — Patient Matching Software

Type of document: Pre-information procedures
Country: United Kingdom
OJEU Ref: (2019/S 042-094659/EN)
Nature of contract: Supply contract
Procedure: Not applicable
Regulation of procurement: EU – with participation by GPA countries
Type of bid required: Not applicable

Prior information notice without call for competition
Supplies

This notice is for prior information only
Section I: Contracting authority
I.1) Name and addresses
Official name: NHS Wales Shared Services Partnership
Postal address: 4-5 Charnwood Court, Heol Billingsley, Parc Nantgarw
Town: Cardiff
Postal code: CF15 7QZ
Country: United Kingdom
Telephone: +44 1443848585
Email: rhian.williams55@wales.nhs.uk
Internet address(es):
Main address:
Address of the buyer profile:

Additional information can be obtained from:
the above mentioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement:
II.1.1) Title: Clinical Trials — Patient Matching Software
II.1.2) Main CPV code: 48000000
II.1.3) Type of contract: Supplies
II.1.4) Short Description:
Establish market readiness of artificial intelligence software Clinical Trials Matching Product to read structured and un-structured data in patient records for the purposes of matching for inclusion/exclusion to/from clinical trials to:
— increase the numbers of pre-screened patients recruited to studies,
— increase the rate at which patients are recruited to studies,
— reduce the screen failure rate,
— support the improvement of participation in clinical trials to speed up studies that may provide better/faster outcomes for patients,
— improve income generated to Trust via participation in clinical trials.
II.1.6) Information about lots:
The contract is divided into lots: no
II.2) Description:
II.2.2)Additional CPV code(s)
Main CPV code: 48000000

II.2.3) Place of performance
Nuts code: UKL22
Main site or place of performance:Cardiff.
II.2.4) Description of the procurement
No contract will be committed to at this stage via the publication of this Prior Information Notice (PIN):
— the Trust plans to proceed with this approach purely to verify the level of available competition and gather credible market information,
— this paper is being submitted for information purposes,
— the production and approval of this paper will not grant authority to commit expenditure on behalf of the Trust,
— via the publication of the PIN, the Trust aims to assure itself of the level of available competition and obtain indicative charges from suppliers, that may support the further development of a Business Case.
II.2.5) Award criteria

II.2.14) Additional information: This PIN is to establish whether suitable suppliers exist. No contract award will result from this exercise.
This is being undertaken to verify market conditions to determine whether suitable suppliers exist.
It is intended to hold a Supplier Day w/c 11.3.2019 in Cardiff with location tbc. There is an option to hold either in person, via WebEX or Skype. Sessions to last up to 2 hours.

II.3) Estimated date of publication of contract notice:2019-03-15
Section IV: Procedure
IV.1) Description
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information

Section VI: Complementary information
VI.2) Information about electronic workflows
VI.3) Additional information:
The following criteria will be used by the Innovation Board to inform strategic direction of the Trust, in relation to the use of AI for the matching of clinical trials:
— availability of Off the Shelf Software (OTS) with ability to automate workflows associated with matching patients for clinical trials,
— establish stability of underlying platform e.g. use of cloud based technology,
— innovation roadmap — future technology changes and pace of development,
— potential commercial and financial impact,
— evidence of product deployed successfully elsewhere/stage of deployment achieved to date for an equivalent purpose,
— product functionality — ability to read structured and un-structured data,
— ability to add value to the Trust i.e. value added in achieving outcomes of matching/excluding patients to/from clinical trials,
— ability to integrate with existing Trust solutions holding patient data and integration support available,
— resources required of the Trust e.g. skills and time,
— establish security and how solutions address GDPR,
— ease of use — implementation, training and further in house development i.e. a solution which is not proprietary to a specific trial,
— pricing strategy/licensing model e.g. enterprise license, license per user/seat, successful patient match (outcome based pricing model), infrastructure investment or cloud model, upgrades and maintenance, etc.
Note: to register your interest in this notice and obtain any additional information please visit the Sell2Wales website at
(WA Ref:90077)

VI.5) Date of dispatch of this notice:2019-02-25